FK 506 versus cyclosporine.
作者信息
Starzl T E
机构信息
Department of Surgery, University of Pittsburgh, Pennsylvania.
出版信息
Transplant Proc. 1993 Feb;25(1 Pt 1):511-2.
Abstract
摘要
相似文献
1
FK 506 versus cyclosporine.FK506与环孢素对比
Transplant Proc. 1993 Feb;25(1 Pt 1):511-2.
2
Japanese multicenter studies of FK 506 in renal transplantation. Japanese FK 506 Study Group.
Transplant Proc. 1995 Feb;27(1):50-3.
3
Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.肝移植和肾移植中环孢素转换为他克莫司的情况。
Transplant Proc. 1996 Dec;28(6):3178-9.
4
Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients.FK506和环孢素在肝移植受者中用作初始免疫抑制时的肾毒性。
Transplant Proc. 1993 Feb;25(1 Pt 1):665-8.
5
Correlation between simplified immunocompetence assay and clinical graft states in kidney or liver transplant recipients.
Transplant Proc. 1996 Jun;28(3):1259.
6
Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy.
Transplant Proc. 1996 Dec;28(6):3165.
7
8
Ten-year results of a randomised prospective study of FK506 versus cyclosporine in management of primary orthotopic liver transplantation.FK506与环孢素用于原位肝移植治疗的随机前瞻性研究的十年结果
Transplant Proc. 2002 Aug;34(5):1507-10. doi: 10.1016/s0041-1345(02)02950-0.
9
FK 506 and cyclosporine: effects and side effects in canine lung transplantation.FK506与环孢素：犬肺移植中的作用及副作用
Transplant Proc. 1991 Dec;23(6):3304-5.
10
FK 506 versus cyclosporine in pediatric liver transplantation.儿童肝移植中FK506与环孢素的比较
Transplant Proc. 1991 Dec;23(6):3010-5.
引用本文的文献
1
Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patient benefits.自1999年以来的无类固醇免疫抑制：129例小儿肾移植，移植肾和患者均持续受益。
Am J Transplant. 2009 Jun;9(6):1362-72. doi: 10.1111/j.1600-6143.2009.02640.x. Epub 2009 May 13.
2
Pediatric renal transplantation under tacrolimus-based immunosuppression.基于他克莫司的免疫抑制下的小儿肾移植
Transplantation. 1999 Jan 27;67(2):299-303. doi: 10.1097/00007890-199901270-00020.
3
Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet.他克莫司（FK506）与制药/学术/监管的重重考验。
Am J Kidney Dis. 1998 Jun;31(6 Suppl 1):S7-14. doi: 10.1053/ajkd.1998.v31.pm9631858.
4
5
Tryptophan dynamics of the FK506 binding protein: time-resolved fluorescence and simulations.FK506结合蛋白的色氨酸动力学：时间分辨荧光与模拟
Biophys J. 1996 Mar;70(3):1122-37. doi: 10.1016/S0006-3495(96)79706-0.
6
Renal transplantation at the University of Pittsburgh: the impact of FK506.匹兹堡大学的肾移植：FK506的影响。
Clin Transpl. 1994:229-36.
7
8
A prospective randomized trial of FK506-based immunosuppression after renal transplantation.肾移植后基于FK506免疫抑制的前瞻性随机试验。
Transplantation. 1995 Feb 27;59(4):485-90. doi: 10.1097/00007890-199559040-00007.
9
Intestinal transplantation.肠道移植
Annu Rev Med. 1994;45:79-91. doi: 10.1146/annurev.med.45.1.79.
10
FK506 in pediatric kidney transplantation--primary and rescue experience.FK506在小儿肾移植中的应用——初次及挽救性治疗经验
Pediatr Nephrol. 1995;9 Suppl(Suppl):S43-8. doi: 10.1007/BF00867683.
本文引用的文献
1
Quality-of-life advantages of FK 506 vs conventional immunosuppressive drug therapy in cardiac transplantation.心脏移植中FK 506相较于传统免疫抑制药物治疗的生活质量优势。
Transplant Proc. 1991 Dec;23(6):3061-4.
2
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver.移植功能对FK506血药浓度、剂量及肾功能的影响，尤其涉及肝脏。
Transplantation. 1991 Jul;52(1):71-7. doi: 10.1097/00007890-199107000-00015.
3
4
Hepatotrophic effects of FK506 in dogs.FK506对犬的肝营养作用。
Transplantation. 1991 Jan;51(1):67-70. doi: 10.1097/00007890-199101000-00010.
5
Intestinal transplantation in composite visceral grafts or alone.复合脏器移植中的肠道移植或单独的肠道移植。
Ann Surg. 1992 Sep;216(3):223-33; discussion 233-4. doi: 10.1097/00000658-199209000-00002.
Zotero 插件